Question

Difficulty: MediumMonitoring and Treatment Evaluation

A 22-year-old woman comes to the dermatology clinic for the management of severe nodulocystic acne. Over the past six months, she has been treated with oral doxycycline and topical benzoyl peroxide, but her condition has worsened. She has deep, painful cystic lesions on her face, back, and chest that are beginning to scar. The physician plans to initiate oral isotretinoin. She has no other medical conditions. Which of the following are essential components of this patient's treatment and monitoring plan? (Select all that apply)

  1. Monthly human chorionic gonadotropin testingAnswer
  2. Baseline and periodic fasting lipid panelAnswer
  3. Baseline and periodic liver aminotransferasesAnswer
  4. D
    Continuation of oral doxycycline for the first month of therapy
  5. E
    Baseline and periodic monitoring of serum creatinine

Answer

The correct components are monthly human chorionic gonadotropin testing, baseline and periodic fasting lipid panels, and baseline and periodic liver aminotransferases.
Isotretinoin is a highly effective but high-risk medication for severe nodulocystic acne. Because it is highly teratogenic, strict adherence to a pregnancy prevention program is mandatory, requiring two negative baseline pregnancy tests and monthly human chorionic gonadotropin (hCG) testing during therapy. Additionally, isotretinoin can cause significant elevations in serum triglycerides and liver aminotransferases. Therefore, a fasting lipid panel and liver function tests must be checked at baseline and monitored periodically (typically after 1-2 months) to evaluate for hypertriglyceridemia and hepatotoxicity.

Parameter / ActionClinical Rationale
Monthly hCGSevere teratogenicity (mandatory prevention program)
Fasting lipid panelRisk of hypertriglyceridemia and pancreatitis
Liver aminotransferasesRisk of hepatotoxicity
Avoid tetracyclinesPrevents pseudotumor cerebri

Step-by-Step Solution

1
Identify the new medication and its primary toxicity profile.
Isotretinoin is a systemic retinoid with significant teratogenic, metabolic, and hepatotoxic risks.
Recognizing the side effect profile is necessary to select appropriate monitoring tests.
2
Select the mandatory laboratory monitoring parameters based on the toxicity profile.
Monthly hCG testing, along with baseline and periodic lipid panels and LFTs, are strictly required.
These tests monitor for pregnancy, hypertriglyceridemia, and transaminitis, which are the most critical adverse effects.
3
Evaluate current medications for absolute contraindications and interactions.
Doxycycline must be discontinued before starting isotretinoin.
Concomitant use of isotretinoin and tetracyclines exponentially increases the risk of idiopathic intracranial hypertension.

Key Concept

Monitoring requirements for isotretinoin therapy include rigorous pregnancy testing, lipid panels, and liver function tests. Concurrent use of tetracyclines must be strictly avoided due to the compounded risk of pseudotumor cerebri.
Rate this question